Structure |
Chemical Name |
CAS |
MF |
![Ivabradine Impurity 21 HCl](/CAS/20210305/GIF/304465-03-0.gif) |
Ivabradine Impurity 21 HCl |
304465-03-0 |
C26H34N2O5 |
![Moxifloxacin EP Impurity C HCl](/) |
Moxifloxacin EP Impurity C HCl |
|
|
![Moxifloxacin Impurity 23](/CAS/20200515/GIF/855661-74-4.gif) |
Moxifloxacin Impurity 23 |
855661-74-4 |
C21H24FN3O4 |
![Solifenacin Related Compound 18](/CAS/20200611/GIF/1225338-27-1.gif) |
Solifenacin Related Compound 18 |
1225338-27-1 |
C23H26N2O2 |
![N-(2-hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl) -N-isopropylformamide](/CAS/20180527/GIF/1447715-45-8.gif) |
N-(2-hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl) -N-isopropylformamide |
1447715-45-8 |
C19H31NO5 |
![Tofacitinib Related Compound](/CAS/20180808/GIF/1206824-85-2.gif) |
Tofacitinib Related Compound |
1206824-85-2 |
C10H18ClN3O |
![Fluvastatin EP impurity A -G](/CAS/20180527/GIF/93957-58-5.gif) |
Fluvastatin EP impurity A -G |
93957-58-5 |
C24H26FNO4 |
![PWKRNMKZGWGSDV-UHFFFAOYSA-N](/CAS/20210111/GIF/1422960-88-0.gif) |
PWKRNMKZGWGSDV-UHFFFAOYSA-N |
1422960-88-0 |
C33H34ClN4+ |
![sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate](/CAS/20180527/GIF/1329502-92-2.gif) |
sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate |
1329502-92-2 |
C33H41N4NaO7 |
![QFJAHHNMKTWTGZ-DZAPPIOQSA-N](/CAS/20210111/GIF/2045402-27-3.gif) |
QFJAHHNMKTWTGZ-DZAPPIOQSA-N |
2045402-27-3 |
C35H36ClNO4S |
![N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide](/CAS/20200119/GIF/1374226-74-0.gif) |
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide |
1374226-74-0 |
C18H24N2O |
![BJQMFFOQQWEWAF-DGBYXFBUSA-N](/CAS/20211123/GIF/1709825-83-1.gif) |
BJQMFFOQQWEWAF-DGBYXFBUSA-N |
1709825-83-1 |
C31H41ClO8 |
![(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20180629/GIF/CB03954746.gif) |
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C23H29FN6O4S |
![(5-Ethyl-1H-imidazol-4-yl)methanol](/CAS/20180629/GIF/38603-74-6.gif) |
(5-Ethyl-1H-imidazol-4-yl)methanol |
38603-74-6 |
C6H10N2O |
![(Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime](/CAS/20180629/GIF/1810761-43-3.gif) |
(Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime |
1810761-43-3 |
C15H16N2O3S |
![ethylidene phthalide](/CAS/20180629/GIF/61658-90-0.gif) |
ethylidene phthalide |
61658-90-0 |
C10H8O2 |
![6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl) -7-methyl-7,9-dihydro-8H-purin-8-one](/CAS/20180629/GIF/1361569-18-7.gif) |
6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl) -7-methyl-7,9-dihydro-8H-purin-8-one |
1361569-18-7 |
C19H15FN8O |
![5-(TRIFLUOROMETHYL)-3-P-TOLYL-1H-PYRAZOLE](/CAS/GIF/219986-64-8.gif) |
5-(TRIFLUOROMETHYL)-3-P-TOLYL-1H-PYRAZOLE |
219986-64-8 |
C11H9F3N2 |
![5-Methyl-3-phenylisoxazol-4-carbonsure](/CAS/GIF/1136-45-4.gif) |
5-Methyl-3-phenylisoxazol-4-carbonsure |
1136-45-4 |
C11H9NO3 |
![Bendamustine Impurity 26](/) |
Bendamustine Impurity 26 |
|
|
![Canagliflozin Impurity 26](/) |
Canagliflozin Impurity 26 |
|
|
![Edoxaban Impurity 37](/CAS/20210111/GIF/2081883-50-1.gif) |
Edoxaban Impurity 37 |
2081883-50-1 |
C14H27N3O3 |
![Imatinib Impurity 10](/) |
Imatinib Impurity 10 |
|
|
![Levofloxacin Impurity 19](/CAS/20200119/GIF/CB04631848.gif) |
Levofloxacin Impurity 19 |
|
C18H20FN3O4 |
![Olanzapine Impurity K](/CAS/20200119/GIF/CB04631934.gif) |
Olanzapine Impurity K |
|
C17H20N4S |
![Ticagrelor Related Compound 55](/) |
Ticagrelor Related Compound 55 |
|
|
![Ticagrelor Related Compound 73](/) |
Ticagrelor Related Compound 73 |
|
|
![Vildagliptin Impurity 10](/) |
Vildagliptin Impurity 10 |
|
|
![Cefaclor Impurity 2](/CAS/20210111/GIF/722547-49-1.gif) |
Cefaclor Impurity 2 |
722547-49-1 |
C17H18N2O3 |
![Cefodizime Impurity F](/) |
Cefodizime Impurity F |
|
|
![Olaparib Impurity F](/) |
Olaparib Impurity F |
|
|
![Ornidazole Impurity G](/) |
Ornidazole Impurity G |
|
|
![Pidotimod Impurity L](/) |
Pidotimod Impurity L |
|
|
![Tadalafil Impuirty 20](/) |
Tadalafil Impuirty 20 |
2924098-58-6 |
|
![Tenofovir Impurity 53](/) |
Tenofovir Impurity 53 |
|
|
![(S)-3-(4-benzylphenoxy)tetrahydrofuran](/CAS/20200119/GIF/CB04635381.gif) |
(S)-3-(4-benzylphenoxy)tetrahydrofuran |
|
C17H18O2 |
![Ampicillin](/CAS/20211123/GIF/1207726-28-0.gif) |
Ampicillin |
1207726-28-0 |
C24H26N4O5S |
![ethyl 2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-
carboxylate](/CAS/20200119/GIF/CB04656137.gif) |
ethyl 2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-
carboxylate |
2375033-35-3 |
C18H20N2O3S |
![(S)-Indacaterol](/CAS/20211123/GIF/1384188-70-8.gif) |
(S)-Indacaterol |
1384188-70-8 |
C24H29ClN2O3 |
![Cefminox Sodium Impurity 3](/CAS/20210111/GIF/1420072-83-8.gif) |
Cefminox Sodium Impurity 3 |
1420072-83-8 |
C16H21N7O6S4 |
![Edaravone Impurity 26](/) |
Edaravone Impurity 26 |
152494-76-3 |
|
![Levofloxacin Impurity 24](/CAS/20200119/GIF/CB04657604.gif) |
Levofloxacin Impurity 24 |
|
C18H20FN3O4 |
![2-(((Z)-(1-(2-Aminothiazol-4-yl)-2-(((2R,3R)-2-methyl-4-oxo-1-sulfoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic Acid](/) |
2-(((Z)-(1-(2-Aminothiazol-4-yl)-2-(((2R,3R)-2-methyl-4-oxo-1-sulfoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic Acid |
|
C13H17N5O8S2 |
![7-[4-[2-[[[4-(3-Carboxy-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinolin-7-yl)-1-piperazinyl]carbonyl]oxy]-3-oxobutyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid](/CAS/20210111/GIF/156834-58-1.gif) |
7-[4-[2-[[[4-(3-Carboxy-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinolin-7-yl)-1-piperazinyl]carbonyl]oxy]-3-oxobutyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid |
156834-58-1 |
C37H36F2N6O9S2 |
![(6R,7S)-7-ACCA](/CAS/20210111/GIF/108260-07-7.gif) |
(6R,7S)-7-ACCA |
108260-07-7 |
C7H7ClN2O3S |
![Enrofloxacin Impurity 1](/CAS/20210111/GIF/1128234-60-5.gif) |
Enrofloxacin Impurity 1 |
1128234-60-5 |
C19H22ClN3O3 |
![Peramivir Impurity 20](/) |
Peramivir Impurity 20 |
|
|
![Ambroxol Impurity 33](/CAS/20200611/GIF/199472-91-8.gif) |
Ambroxol Impurity 33 |
199472-91-8 |
C13H20N2O |
![Bilastine Impurity 12](/CAS/20210305/GIF/1638785-18-8.gif) |
Bilastine Impurity 12 |
1638785-18-8 |
C30H42N4O3 |
![Tadalafil Impurity 66](/CAS/20200611/GIF/1598416-07-9.gif) |
Tadalafil Impurity 66 |
1598416-07-9 |
C21H18N2O5 |
![Peramivir Impurity 36](/) |
Peramivir Impurity 36 |
|
|
![4-CHLORO-7-(2-CHLORO-ETHOXY)-6-(2-METHOXY-ETHOXY)-QUINAZOLINE](/StructureFile/ChemBookStructure22/GIF/CB1648559.gif) |
4-CHLORO-7-(2-CHLORO-ETHOXY)-6-(2-METHOXY-ETHOXY)-QUINAZOLINE |
183322-20-5 |
C13H14Cl2N2O3 |
![METHYL 2-(O-NITROBENZYLIDENE)-ACETOACETATE](/CAS/GIF/39562-27-1.gif) |
METHYL 2-(O-NITROBENZYLIDENE)-ACETOACETATE |
39562-27-1 |
C12H11NO5 |
![Sugammadex sodium Impurity 48](/) |
Sugammadex sodium Impurity 48 |
|
|
![Sugammadex sodium Impurity 47](/) |
Sugammadex sodium Impurity 47 |
|
|
![Tenofovir Impurity 95](/CAS/20200611/GIF/1884329-63-8.gif) |
Tenofovir Impurity 95 |
1884329-63-8 |
C8H10BrN5 |
![Tenofovir Impurity 117](/CAS/20211123/GIF/1643116-22-6.gif) |
Tenofovir Impurity 117 |
1643116-22-6 |
C8H11N5O |
![Tafluprost Impurity E](/) |
Tafluprost Impurity E |
|
|
![Cabozantinib impurity 36](/) |
Cabozantinib impurity 36 |
|
|
![Dapoxetine impurity 69](/) |
Dapoxetine impurity 69 |
|
|
![4-FLUORO-2-METHYLBENZAMIDE](/StructureFile/ChemBookStructure7/GIF/CB1725304.gif) |
4-FLUORO-2-METHYLBENZAMIDE |
886501-45-7 |
C8H8FNO |
![1-{[4-BENZYL-2-(3,4-DIMETHOXYPHENYL)-4H-CHROMEN-3-YL]METHYL}PIPERIDINIUM CHLORIDE](/StructureFile/ChemBookStructure20/GIF/CB1801273.gif) |
1-{[4-BENZYL-2-(3,4-DIMETHOXYPHENYL)-4H-CHROMEN-3-YL]METHYL}PIPERIDINIUM CHLORIDE |
|
C30H34ClNO3 |
![4-Hydroxyisophthalonitrile](/StructureFile/ChemBookStructure20/GIF/CB1801374.gif) |
4-Hydroxyisophthalonitrile |
34133-58-9 |
C8H4N2O |
![Empagliflozin Impurity 81](/) |
Empagliflozin Impurity 81 |
|
|
![Iohexol Impurity M](/) |
Iohexol Impurity M |
|
|
![Relugolix Impurity 18](/) |
Relugolix Impurity 18 |
|
|
![Rabeprazole Impurity 15](/) |
Rabeprazole Impurity 15 |
|
|
![4-((2-amino-2-oxoethyl)(hydroxy)amino)butanoic acid](/CAS/20210111/GIF/2454698-45-2.gif) |
4-((2-amino-2-oxoethyl)(hydroxy)amino)butanoic acid |
2454698-45-2 |
C6H12N2O4 |
![Lenvatinib Impurity LFZZ-8](/CAS/20181212/GIF/CB18058114.gif) |
Lenvatinib Impurity LFZZ-8 |
|
C44H40Cl2N8O8 |
![Pemetrexed disodium Impurity 19](/) |
Pemetrexed disodium Impurity 19 |
|
|
![Brivaracetam Impurity 32](/) |
Brivaracetam Impurity 32 |
|
|
![1-((2R,3R)-3-(4-(aminomethyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((methyl(3-((2-(methylamino)acetoxy)methyl)pyridin-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium chloride](/) |
1-((2R,3R)-3-(4-(aminomethyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((methyl(3-((2-(methylamino)acetoxy)methyl)pyridin-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium chloride |
|
|
![Ticagrelor Impurity 107](/) |
Ticagrelor Impurity 107 |
|
|
![Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester](/CAS/20211123/GIF/1682660-39-4.gif) |
Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester |
1682660-39-4 |
C29H33N3O4 |
![sodium 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-3-hydroxypropanoate](/) |
sodium 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-3-hydroxypropanoate |
|
|
![(4S,6R)-((4R,6S)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl 6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylate](/) |
(4S,6R)-((4R,6S)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl 6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylate |
|
|
![tert-butyl 2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-2-methyl-4- oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methyl propanoate](/) |
tert-butyl 2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-2-methyl-4- oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methyl propanoate |
|
|
![Atomoxetine Impurity 15](/CAS/20210111/GIF/881995-45-5.gif) |
Atomoxetine Impurity 15 |
881995-45-5 |
C19H23NO2 |
![Pitavastatin Impurity 13 (Pitavastatin 2,4,6-Triene Impurity)](/CAS/20210111/GIF/2086271-67-0.gif) |
Pitavastatin Impurity 13 (Pitavastatin 2,4,6-Triene Impurity) |
2086271-67-0 |
C25H20FNO2 |
![(2S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2- carboxylic acid sodium](/) |
(2S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2- carboxylic acid sodium |
|
|
![impurity 39](/) |
impurity 39 |
|
|
![(2R,3R,4R,5S)-6-((2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)phenyl)amino)hexane-1,2,3,4,5-pentaol](/) |
(2R,3R,4R,5S)-6-((2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)phenyl)amino)hexane-1,2,3,4,5-pentaol |
|
|
![Bosutinib Impurity 32](/) |
Bosutinib Impurity 32 |
|
|
![6,6'-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one](/CAS/20210111/GIF/1365727-09-8.gif) |
6,6'-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one |
1365727-09-8 |
C29H26N2O2 |
![Ampicillin Dimer Disodium Salt](/CAS/20211123/GIF/94730-51-5.gif) |
Ampicillin Dimer Disodium Salt |
94730-51-5 |
C32H39N6NaO8S2 |
![4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-(tetrahydro-2-furanyl)-, [5R-[3(S*),5α,6α(R*)]]- (9CI)](/CAS/20211123/GIF/106560-13-8.gif) |
4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-(tetrahydro-2-furanyl)-, [5R-[3(S*),5α,6α(R*)]]- (9CI) |
106560-13-8 |
C12H15NO5S |
![1-Naphthalenecarboxylic acid, 8-[[(3S)-1-azabicyclo[2.2.2]oct-3-ylamino]methyl]-5,6,7,8-tetrahydro-, (8S)-](/CAS/20210111/GIF/2407763-21-5.gif) |
1-Naphthalenecarboxylic acid, 8-[[(3S)-1-azabicyclo[2.2.2]oct-3-ylamino]methyl]-5,6,7,8-tetrahydro-, (8S)- |
2407763-21-5 |
C19H26N2O2 |
![Peramivir Impurity 58](/) |
Peramivir Impurity 58 |
|
|
![1-Naphthalenamine, 4-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4R)-rel-](/CAS/20210111/GIF/2124277-87-6.gif) |
1-Naphthalenamine, 4-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4R)-rel- |
2124277-87-6 |
C17H17Cl2N |
![Voriconazole toxic impurity 2](/) |
Voriconazole toxic impurity 2 |
|
|
![Cisatracurium besylate impurity19](/CAS/20211123/GIF/96946-52-0.gif) |
Cisatracurium besylate impurity19 |
96946-52-0 |
C59H77N2O15S+ |
![Bumetanide Impurity 3](/) |
Bumetanide Impurity 3 |
|
|
![Cefoxitin EP Impurity F (S-methoxy cefoxitin)](/) |
Cefoxitin EP Impurity F (S-methoxy cefoxitin) |
|
|
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2514949-81-4.gif) |
INDEX NAME NOT YET ASSIGNED |
2514949-81-4 |
C20H28N4O2 |
![α-[4-[2-(Dimethylamino)ethoxy]phenyl]-β-ethyl-α-phenylphenethylalkohol](/CAS/GIF/748-97-0.gif) |
α-[4-[2-(Dimethylamino)ethoxy]phenyl]-β-ethyl-α-phenylphenethylalkohol |
748-97-0 |
C26H31NO2 |
![Brivaracetam Impurity 53](/) |
Brivaracetam Impurity 53 |
|
|
![Ethyl-[R-(R*,R*)]-hydrogentartrat](/CAS/GIF/608-89-9.gif) |
Ethyl-[R-(R*,R*)]-hydrogentartrat |
608-89-9 |
C6H10O6 |
![ethyl 2,2,4-trichloro-3-oxobutyrate](/CAS/GIF/85153-67-9.gif) |
ethyl 2,2,4-trichloro-3-oxobutyrate |
85153-67-9 |
C6H7Cl3O3 |
![Neodigoxin](/) |
Neodigoxin |
55576-67-5 |
C41H64O14 |
![(S)-6-((R)-2-amino-2-phenylacetamido)-2,2-dimethyl-7-oxo-2,3,4,7-tetrahydro-1,4-thiazepine-3-carboxylic acid](/) |
(S)-6-((R)-2-amino-2-phenylacetamido)-2,2-dimethyl-7-oxo-2,3,4,7-tetrahydro-1,4-thiazepine-3-carboxylic acid |
|
|